Sidiropoulos PI et al. – The presence of inflammatory cytokines together with the well-documented increased risk for cardiovascular diseases in patients with inflammatory arthritides and systemic lupus erythematosus has prompted studies to examine the prevalence of the metabolic syndrome.
A review to identify subjects at risk in addition to that conferred by traditional cardiovascular risk factors
The studies presented here have documented a high prevalence of metabolic syndrome which correlates with disease activity and markers of atherosclerosis
The correlation of inflammatory disease activity with metabolic syndrome provides additional evidence for a link between inflammation and metabolic disturbances/vascular morbidity
See all
